Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 303
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1,251–1,300 of 1,926 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02055313	Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival	completed	—	20	Meir Medical CenterOTHER	0	Feb 25, 2021	clinicaltrials
NCT03115541	Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection	completed	—	187	McMaster UniversityOTHER	3	Feb 24, 2021	clinicaltrials